Merck Sharp & Dohme B.V v. Mankind Pharma Limited

Court

District Court, D. New Jersey (D.N.J.)
Official Court Website →

Assigned judge

Claire C. Cecchi · 12,702 cases in index

Docket number

2:20-cv-02787

Nature of suit

835
Hatch-Waxman patent disputes over a generic-drug (ANDA) application.

Jurisdiction

Federal question

Date filed

03/13/2020

Date terminated

08/24/2020

623 Patent - ANDA cases in this court are indexed here.

Parties

• plaintiff · Merck Sharp & Dohme B.V · 21 cases
• defendant · Mankind Pharma Limited · 2 cases

Part of a Larger Litigation Pattern

This is one of 3 Patent - ANDA cases in our index naming Mankind Pharma Limited — a possible mass-tort or coordinated-litigation cluster.

• Bayer Intellectual Property GmbH v. Mankind Pharma Limited
  District Court, D. DelawareFiled 11/24/2025

About Patent - ANDA Lawsuits

ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

Frequently Asked Questions

What is Merck Sharp & Dohme B.V v. Mankind Pharma Limited?

Merck Sharp & Dohme B.V v. Mankind Pharma Limited is a federal patent - anda lawsuit filed on 03/13/2020 in the District Court, D. New Jersey. The case was terminated on 08/24/2020. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What type of case is this?

It is classified as “Patent - ANDA” under the federal nature-of-suit system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What court is the case in?

The case is in the District Court, D. New Jersey, docket number 2:20-cv-02787.

When was the case filed?

Merck Sharp & Dohme B.V v. Mankind Pharma Limited was filed on 03/13/2020. It was terminated on 08/24/2020.